Medical devices, healthcare technology and the business of care
510(k) clearance · K263010

ISIS Headboxes, ISIS Neurostimulator, ISIS Xpert Plus, ISIS Xpert, ISIS Xpress

inomed Medizintechnik GmbH · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK263010

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 24, 2026 for K263010, a 510(k) premarket notification from inomed Medizintechnik GmbH covering ISIS Headboxes, ISIS Neurostimulator, ISIS Xpert Plus, ISIS Xpert and ISIS Xpress. The listed classification is an electrical evoked-response stimulator, product code GWF, medical specialty Neurology. A SESE decision is a clearance finding, not premarket approval of the system.

The reviewed documents describe the ISIS Neurostimulator as an evoked-response stimulator with 12 channels for high-current stimulation and one channel for low-current stimulation, and describe the systems as supplied pre-configured as medical systems. The documents also reference evoked potentials, EEG and intraoperative monitoring functions. The source data do not state which components changed relative to the predicate, the predicate device, or any clinical performance data, so those points remain unknown.

The record shows a submission date of 08/28/2026 and a decision date of 09/24/2026, with the applicant listed at Im Hausgruen 29, Emmendingen, Germany. No indications, patient-selection criteria or treatment parameters are established here; those would reside in the original FDA documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Sep 24, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263010
Regulatory pathway
510(k) premarket notification
Product code
GWF
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, Electrical, Evoked Response.

Product code
GWF
FDA device class
2

FDA decision timeline

  1. K263010 received

    Application receipt date recorded by FDA.

  2. K263010 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

inomed Medizintechnik GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Emmendingen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records